- Home
- ARWR vs REZI Comparison
ARWR vs REZI Comparison
Compare ARWR & REZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- REZI
- Stock Information
- Founded
- ARWR 2003
- REZI 2018
- Country
- ARWR United States
- REZI United States
- Employees
- ARWR N/A
- REZI N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- REZI Wholesale Distributors
- Sector
- ARWR Health Care
- REZI Industrials
- Exchange
- ARWR Nasdaq
- REZI Nasdaq
- Market Cap
- ARWR 5.1B
- REZI 6.1B
- IPO Year
- ARWR 1993
- REZI N/A
- Fundamental
- Price
- ARWR $39.24
- REZI $43.47
- Analyst Decision
- ARWR Strong Buy
- REZI Buy
- Analyst Count
- ARWR 8
- REZI 3
- Target Price
- ARWR $47.75
- REZI $34.67
- AVG Volume (30 Days)
- ARWR 1.8M
- REZI 1.2M
- Earning Date
- ARWR 11-25-2025
- REZI 11-05-2025
- Dividend Yield
- ARWR N/A
- REZI N/A
- EPS Growth
- ARWR N/A
- REZI N/A
- EPS
- ARWR N/A
- REZI N/A
- Revenue
- ARWR $572,976,000.00
- REZI $7,399,000,000.00
- Revenue This Year
- ARWR $21,287.22
- REZI $13.22
- Revenue Next Year
- ARWR N/A
- REZI $3.40
- P/E Ratio
- ARWR N/A
- REZI N/A
- Revenue Growth
- ARWR 2816.20
- REZI 20.00
- 52 Week Low
- ARWR $9.57
- REZI $14.18
- 52 Week High
- ARWR $40.48
- REZI $45.29
- Technical
- Relative Strength Index (RSI)
- ARWR 65.60
- REZI 59.61
- Support Level
- ARWR $36.73
- REZI $43.11
- Resistance Level
- ARWR $40.48
- REZI $45.29
- Average True Range (ATR)
- ARWR 1.70
- REZI 1.46
- MACD
- ARWR -0.20
- REZI -0.07
- Stochastic Oscillator
- ARWR 78.79
- REZI 69.22
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About REZI Resideo Technologies Inc.
Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions; and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.